The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions
Open accessAbstract
SUMMARY: The spread of Enterobacteriaceae , primarily Klebsiella pneumoniae , producing KPC, VIM, IMP, and NDM carbapenemases, is causing an unprecedented public health crisis. Carbapenemase-producing enterobacteria (CPE) infect mainly hospitalized patients but also have been spreading in long-term care facilities. Given their multidrug resistance, therapeutic options are limited and, as discussed here, should be reevaluated and optimized. Based on susceptibility data, colistin and tigecycline are commonly used to treat CPE infections. Nevertheless, a review of the literature revealed high failure rates in cases of monotherapy with these drugs, whilst monotherapy with either a carbapenem or an aminoglycoside appeared to be more effective. Combination therapies not including carbapenems were comparable to aminoglycoside and carbapenem monotherapies. Higher success rates have been achieved with carbapenem-containing combinations. Pharmacodynamic simulations and experimental infections indicate that modification of the current patterns of carbapenem use against CPE warrants further attention. Epidemiological data, though fragmentary in many countries, indicate CPE foci and transmission routes, to some extent, whilst also underlining the lack of international collaborative systems that could react promptly and effectively. Fortunately, there are sound studies showing successful containment of CPE by bundles of measures, among which the most important are active surveillance cultures, separation of carriers, and assignment of dedicated nursing staff.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical and Laboratory Standards Institute
(2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_300416 · Cited by 5,091
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Podschun, R., & Ullmann, U. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.4.589 · Cited by 2,688
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Multiplex PCR for detection of acquired carbapenemase genes
Poirel, L., Walsh, T. R., Cuvillier, V., & Nordmann, P. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.12.002 · Cited by 1,991
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
Dallenne, C., Da Costa, A., Decré, D., Favier, C., & Arlet, G. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp498 · Cited by 1,655
Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639 · cited 4×
“It has been estimated that in 688 cmr.asm.org Clinical Microbiology Reviews Greek hospitals, some 10 to 15% of CPE (a bacterial population consisting mainly of KPC-2-producing K. pneumoniae strains) appear resistant by the CLSI interpretive criteria but susceptible according to EUCAST (Daikos, unpublished data).”
BackgroundInfluentialThe real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Nordmann, P., Cuzon, G., & Naas, T. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70054-4 · Cited by 1,579
Metallo-β-Lactamases: the Quiet before the Storm?
Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.306-325.2005 · Cited by 1,431
Walsh, T. R., Weeks, J., Livermore, D. M., & Toleman, M. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70059-7 · Cited by 1,250
Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae
Poirel, L., Héritier, C., Tolün, V., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.15-22.2004 · Cited by 997
Patel, G., Huprikar, S., Factor, S. H., Jenkins, S. G., & Calfee, D. P. (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/592412 · Cited by 836
Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines
Agwuh, K. N. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl224 · Cited by 806
Garonzik, S. M., Li, J., Thamlikitkul, V., Paterson, D. L., Shoham, S., Jacob, J., Silveira, F. P., Forrest, A., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01733-10 · Cited by 696
Metallo-β-lactamases: a last frontier for β-lactams?
Cornaglia, G., Giamarellou, H., & Rossolini, G. M. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70056-1 · Cited by 613
Bratu, S., Landman, D., Haag, R., Recco, R., Eramo, A., Alam, M., & Quale, J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1430 · Cited by 573
Kitchel, B., Rasheed, J. K., Patel, J. B., Srinivasan, A., Navon-Venezia, S., Carmeli, Y., Brolund, A., & Giske, C. G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00126-09 · Cited by 522
Genetic Structures at the Origin of Acquisition of the β-Lactamase bla KPC Gene
Naas, T., Cuzon, G., Villegas, M.-V., Lartigue, M.-F., Quinn, J. P., & Nordmann, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01451-07 · Cited by 515
Bebrone, C. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.05.021 · Cited by 505
Walther-Rasmussen, J., & Høiby, N. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki482 · Cited by 495
Plachouras, D., Karvanen, M., Friberg, L. E., Papadomichelakis, E., Antoniadou, A., Tsangaris, I., Karaiskos, I., Poulakou, G., Kontopidou, F., Armaganidis, A., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01361-08 · Cited by 494
Bradford, P. A., Bratu, S., Urban, C., Visalli, M., Mariano, N., Landman, D., Rahal, J. J., Brooks, S., Cebular, S., & Quale, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421495 · Cited by 485
Schwaber, M. J., Klarfeld-Lidji, S., Navon-Venezia, S., Schwartz, D., Leavitt, A., & Carmeli, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01020-07 · Cited by 483
Hirsch, E. B., & Tam, V. H. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq108 · Cited by 477
Schwaber, M. J., Lev, B., Israeli, A., Solter, E., Smollan, G., Rubinovitch, B., Shalit, I., Carmeli, Y., & the Israel Carbapenem-Resistant Enterobacteriaceae Working Group (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir025 · Cited by 453
Woodford, N., Tierno, P. M., Young, K., Tysall, L., Palepou, M.-F. I., Ward, E., Painter, R. E., Suber, D. F., Shungu, D., Silver, L. L., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4793-4799.2004 · Cited by 442
Osano, E., Arakawa, Y., Wacharotayankun, R., Ohta, M., Horii, T., Ito, H., Yoshimura, F., & Kato, N. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.1.71 · Cited by 440
Zarkotou, O., Pournaras, S., Tselioti, P., Dragoumanos, V., Pitiriga, V., Ranellou, K., Prekates, A., Themeli-Digalaki, K., & Tsakris, A. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03514.x · Cited by 438
Lledo, W., Hernández, M., Lopez, E., Molinari, O. L., Soto, R. Q., Hernández, E., Vispo, N. S., Flores, M., Vázquez, G. J., Robledo, I. E., et al. (2009) · PubMed · Cited by 430
Senda, K., Arakawa, Y., Ichiyama, S., Nakashima, K., Ito, H., Ohsuka, S., Shimokata, K., Kato, N., & Ohta, M. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.12.2909-2913.1996 · Cited by 416
Lederman, E. R., & Crum, N. F. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40310.x · Cited by 401
Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
Borer, A., Saidel-Odes, L., Riesenberg, K., Eskira, S., Peled, N., Nativ, R., Schlaeffer, F., & Sherf, M. (2009) · Infection Control & Hospital Epidemiology · doi:10.1086/605922 · Cited by 389
Castanheira, M., Deshpande, L. M., Mathai, D., Bell, J. M., Jones, R. N., & Mendes, R. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01497-10 · Cited by 362
Rapid detection of carbapenemase genes by multiplex real-time PCR
Monteiro, J., Widen, R. H., Pignatari, A. C. C., Kubasek, C., & Silbert, S. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr563 · Cited by 358
Extended-Spectrum-β-Lactamase, AmpC, and Carbapenemase Issues
Thomson, K. S. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00219-10 · Cited by 356
Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections
Ben-David, D., Kordevani, R., Keller, N., Tal, I., Marzel, A., Gal-Mor, O., Maor, Y., & Rahav, G. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03478.x · Cited by 353
Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues
Miriagou, V., Cornaglia, G., Edelstein, M., Galani, I., Giske, C. G., Gniadkowski, M., Malamou-Lada, E., Martinez-Martinez, L., Navarro, F., Nordmann, P., et al. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03116.x · Cited by 350
Livermore, D. M., Warner, M., Mushtaq, S., Doumith, M., Zhang, J., & Woodford, N. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.01.012 · Cited by 341
Gales, A. C., Jones, R. N., & Sader, H. S. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr239 · Cited by 337
Burckhardt, I., & Zimmermann, S. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00287-11 · Cited by 335
Hrabák, J., Walková, R., Študentová, V., Chudáčková, E., & Bergerová, T. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00984-11 · Cited by 310
Bratu, S., Tolaney, P., Karumudi, U., Quale, J., Mooty, M., Nichani, S., & Landman, D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki175 · Cited by 307
Worldwide Diversity of Klebsiella pneumoniae That Produce β-Lactamase blaKPC-2Gene1
Cuzon, G., Naas, T., Truong, H., Villegas, M.-V., Wisell, K. T., Carmeli, Y., Gales, A. C., Navon-Venezia, S., Quinn, J. P., & Nordmann, P. (2010) · Emerging Infectious Diseases · doi:10.3201/eid1609.091389 · Cited by 307
Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae
Gasink, L. B., Edelstein, P. H., Lautenbach, E., Synnestvedt, M., & Fishman, N. O. (2009) · Infection Control & Hospital Epidemiology · doi:10.1086/648451 · Cited by 306
Falagas, M. E., Rafailidis, P. I., Ioannidou, E., Alexiou, V. G., Matthaiou, D. K., Karageorgopoulos, D. E., Kapaskelis, A., Nikita, D., & Michalopoulos, A. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.10.005 · Cited by 300
Carbapenem-Resistant Enterobacteriaceae: A Potential Threat
(2008) · JAMA · doi:10.1001/jama.2008.896 · Cited by 298
Nordmann, P., Poirel, L., Toleman, M. A., & Walsh, T. R. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq520 · Cited by 294
Habitat Association of Klebsiella Species
Bagley, S. T. (1985) · Infection Control · doi:10.1017/s0195941700062603 · Cited by 291
Mendes, R. E., Kiyota, K. A., Monteiro, J., Castanheira, M., Andrade, S. S., Gales, A. C., Pignatari, A. C. C., & Tufik, S. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01728-06 · Cited by 287
Grundmann, H., Livermore, D. M., Giske, C. G., Cantón, R., Rossolini, G. M., Campos, J., Vatopoulos, A., Gniadkowski, M., Toth, A., Pfeifer, Y., et al. (2010) · Eurosurveillance · doi:10.2807/ese.15.46.19711-en · Cited by 284
Spread of OXA-48-Encoding Plasmid in Turkey and Beyond
Carrër, A., Poirel, L., Yilmaz, M., Akan, O. A., Feriha, C., Cuzon, G., Matar, G., Honderlick, P., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01312-09 · Cited by 273
Antoniadou, A., Kontopidou, F., Poulakou, G., Koratzanis, E., Galani, I., Papadomichelakis, E., Kopterides, P., Souli, M., Armaganidis, A., & Giamarellou, H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl562 · Cited by 273
Souli, M., Galani, I., Antoniadou, A., Papadomichelakis, E., Poulakou, G., Panagea, T., Vourli, S., Zerva, L., Armaganidis, A., Kanellakopoulou, K., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649865 · Cited by 271
Revised Ambler classification of β-lactamases
Hall, B. G., & Barlow, M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki130 · Cited by 270
Lemmen, S. W., Häfner, H., Zolldann, D., Stanzel, S., & Lütticken, R. (2004) · Journal of Hospital Infection · doi:10.1016/j.jhin.2003.12.004 · Cited by 266
Efficacy and safety of tigecycline: a systematic review and meta-analysis
Yahav, D., Lador, A., Paul, M., & Leibovici, L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr242 · Cited by 266
Leavitt, A., Navon-Venezia, S., Chmelnitsky, I., Schwaber, M. J., & Carmeli, Y. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00299-07 · Cited by 256
Carmeli, Y., Akova, M., Cornaglia, G., Daikos, G. L., Garau, J., Harbarth, S., Rossolini, G. M., Souli, M., & Giamarellou, H. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03115.x · Cited by 253
Self-citationRisk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study
Falagas, M. E., Rafailidis, P. I., Kofteridis, D. P., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm356 · Cited by 253
Bratu, S., Mooty, M., Nichani, S., Landman, D., Gullans, C., Pettinato, B., Karumudi, U., Tolaney, P., & Quale, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.3018-3020.2005 · Cited by 246
Emergence of Metallo-β-Lactamase NDM-1-Producing Multidrug-Resistant Escherichia coli in Australia
Poirel, L., Lagrutta, E., Taylor, P., Pham, J., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00878-10 · Cited by 243
Biological Costs and Mechanisms of Fosfomycin Resistance in Escherichia coli
Nilsson, A. I., Berg, O. G., Aspevall, O., Kahlmeter, G., & Andersson, D. I. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2850-2858.2003 · Cited by 241
Won, S. Y., Munoz-Price, L. S., Lolans, K., Hota, B., Weinstein, R. A., Hayden, M. K., & Program, F. T. C. F. D. C. A. P. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir482 · Cited by 240
Creeping baselines and adaptive resistance to antibiotics
Fernández, L., Breidenstein, E. B. M., & Hancock, R. E. W. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.01.001 · Cited by 238
Daikos, G. L., & Markogiannakis, A. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03553.x · Cited by 238
Self-citationLaraki, N., Franceschini, N., Rossolini, G. M., Santucci, P., Meunier, C., de Pauw, E., Amicosante, G., Frère, J. M., & Galleni, M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.902 · Cited by 233
Virginia Villegas, M., Lolans, K., Correa, A., Jose Suarez, C., Lopez, J. A., Vallejo, M., & Quinn, J. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00186-06 · Cited by 232
Page, M. G. P., Dantier, C., & Desarbre, E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01525-09 · Cited by 227
Pasterán, F. G., Mendez, T., Guerriero, L., Rapoport, M., & Corso, A. C. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00130-09 · Cited by 225
Endimiani, A., Hujer, A. M., Perez, F., Bethel, C. R., Hujer, K. M., Kroeger, J., Oethinger, M., Paterson, D. L., Adams, M. D., Jacobs, M. R., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn547 · Cited by 216
Hussein, K., Sprecher, H., Mashiach, T., Oren, I., Kassis, I., & Finkelstein, R. (2009) · Infection Control & Hospital Epidemiology · doi:10.1086/598244 · Cited by 215
Borer, A., Saidel-Odes, L., Eskira, S., Nativ, R., Riesenberg, K., Livshiz-Riven, I., Schlaeffer, F., Sherf, M., & Peled, N. (2012) · American Journal of Infection Control · doi:10.1016/j.ajic.2011.05.022 · Cited by 213
Anthony, K. B., Fishman, N. O., Linkin, D. R., Gasink, L. B., Edelstein, P. H., & Lautenbach, E. (2008) · Clinical Infectious Diseases · doi:10.1086/526775 · Cited by 210
Daikos, G. L., Petrikkos, P., Psichogiou, M., Kosmidis, C., Vryonis, E., Skoutelis, A., Georgousi, K., Tzouvelekis, L. S., Tassios, P. T., Bamia, C., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00782-08 · Cited by 210
Self-citationMarchaim, D., Chopra, T., Pogue, J. M., Perez, F., Hujer, A. M., Rudin, S., Endimiani, A., Navon-Venezia, S., Hothi, J., Slim, J., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01020-10 · Cited by 208
Dudhani, R. V., Turnidge, J. D., Coulthard, K., Milne, R. W., Rayner, C. R., Li, J., & Nation, R. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01114-09 · Cited by 205
Plasmid-Mediated KPC-2 in a Klebsiella pneumoniae Isolate from China
Wei, Z.-Q., Du, X.-X., Yu, Y.-S., Shen, P., Chen, Y.-G., & Li, L.-J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01053-06 · Cited by 205
Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem
Kuti, J. L., Dandekar, P. K., Nightingale, C. H., & Nicolau, D. P. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003257225 · Cited by 199
Carbapenem Resistance in Klebsiella pneumoniae Not Detected by Automated Susceptibility Testing
Tenover, F. C., Kalsi, R. K., Williams, P. P., Carey, R. B., Stocker, S., Lonsway, D., Rasheed, J. K., Biddle, J. W., McGowan, J. E., & Hanna, B. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1208.060291 · Cited by 199
Marchaim, D., Navon-Venezia, S., Schwaber, M. J., & Carmeli, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01103-07 · Cited by 195
Perez, F., Endimiani, A., Ray, A. J., Decker, B. K., Wallace, C. J., Hujer, K. M., Ecker, D. J., Adams, M. D., Toltzis, P., Dul, M. J., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq191 · Cited by 194
Landman, D., Bratu, S., Kochar, S., Panwar, M., Trehan, M., Doymaz, M., & Quale, J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm129 · Cited by 192
Kochar, S., Sheard, T., Sharma, R., Hui, A., Tolentino, E., Allen, G., Landman, D., Bratu, S., Augenbraun, M., & Quale, J. (2009) · Infection Control & Hospital Epidemiology · doi:10.1086/596734 · Cited by 191
Naas, T., Nordmann, P., Vedel, G., & Poyart, C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4423-4424.2005 · Cited by 190
Peleg, A. Y., Franklin, C., Bell, J. M., & Spelman, D. W. (2005) · Clinical Infectious Diseases · doi:10.1086/497831 · Cited by 190
Perry, J. D., Naqvi, S. H., Mirza, I. A., Alizai, S. A., Hussain, A., Ghirardi, S., Orenga, S., Wilkinson, K., Woodford, N., Zhang, J., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr299 · Cited by 188
Carbapenem-Resistant Strain of Klebsiellaoxytoca Harboring Carbapenem-Hydrolyzingβ-LactamaseKPC-2
Yigit, H., Queenan, A. M., Rasheed, J. K., Biddle, J. W., Domenech-Sanchez, A., Alberti, S., Bush, K., & Tenover, F. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3881-3889.2003 · Cited by 187
In vitro activity of AVE1330A, an innovative broad-spectrum non- -lactam -lactamase inhibitor
Bonnefoy, A. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh358 · Cited by 185
Dudhani, R. V., Turnidge, J. D., Nation, R. L., & Li, J. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq226 · Cited by 181
Stachyra, T., Levasseur, P., Pechereau, M.-C., Girard, A.-M., Claudon, M., Miossec, C., & Black, M. T. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp197 · Cited by 180
Samonis, G., Maraki, S., Karageorgopoulos, D. E., Vouloumanou, E. K., & Falagas, M. E. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1360-5 · Cited by 177
Docquier, J.-D., Calderone, V., De Luca, F., Benvenuti, M., Giuliani, F., Bellucci, L., Tafi, A., Nordmann, P., Botta, M., Rossolini, G. M., et al. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.04.010 · Cited by 176
Ho, P. L., Lo, W. U., Yeung, M. K., Lin, C. H., Chow, K. H., Ang, I., Tong, A. H. Y., Bao, J. Y.-J., Lok, S., & Lo, J. Y. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017989 · Cited by 175
Ben-David, D., Maor, Y., Keller, N., Regev-Yochay, G., Tal, I., Shachar, D., Zlotkin, A., Smollan, G., & Rahav, G. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/652528 · Cited by 171
Mouloudi, E. K., Protonotariou, E., Zagorianou, A., Iosifidis, Ε., Karapanagiotou, A., Giasnetsova, T., Tsioka, A., Roilides, E., Sofianou, D., & Gritsi-Gerogianni, N. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/657135 · Cited by 171
Population Pharmacokinetic Analysis and Dosing Regimen Optimization of Meropenem in Adult Patients
Li, C., Kuti, J. L., Nightingale, C. H., & Nicolau, D. P. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006291035 · Cited by 171
Samuelsen, O., Naseer, U., Tofteland, S., Skutlaberg, D. H., Onken, A., Hjetland, R., Sundsfjord, A., & Giske, C. G. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp018 · Cited by 171
Characterization of OXA-181, a Carbapenem-Hydrolyzing Class D β-Lactamase from Klebsiella pneumoniae
Potron, A., Nordmann, P., Lafeuille, E., Al Maskari, Z., Al Rashdi, F., & Poirel, L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00481-11 · Cited by 170
Poirel, L., Bonnin, R. A., & Nordmann, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00165-11 · Cited by 169
Characterization of OXA-204, a Carbapenem-Hydrolyzing Class D β-Lactamase from Klebsiella pneumoniae
Potron, A., Nordmann, P., & Poirel, L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01034-12 · Cited by 169
Bogdanovich, T., Adams-Haduch, J. M., Tian, G.-B., Nguyen, M. H., Kwak, E. J., Muto, C. A., & Doi, Y. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir401 · Cited by 168
Therapeutic Options for Infections with Enterobacteriaceae Producing Carbapenem-Hydrolyzing Enzymes
Falagas, M. E., Karageorgopoulos, D. E., & Nordmann, P. (2011) · Future Microbiology · doi:10.2217/fmb.11.49 · Cited by 167
Munoz-Price, L. S., Hayden, M. K., Lolans, K., Won, S., Calvert, K., Lin, M., Sterner, A., & Weinstein, R. A. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651097 · Cited by 167
On functional and structural heterogeneity of VIM-type metallo-beta-lactamases
Docquier, J.-D. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg067 · Cited by 167
Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections
Neuner, E. A., Yeh, J.-Y., Hall, G. S., Sekeres, J., Endimiani, A., Bonomo, R. A., Shrestha, N. K., Fraser, T. G., & van Duin, D. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.10.013 · Cited by 166
Cheng, H.-Y., Chen, Y.-F., & Peng, H.-L. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-60 · Cited by 166
Pournaras, S., Vrioni, G., Neou, E., Dendrinos, J., Dimitroulia, E., Poulou, A., & Tsakris, A. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.10.031 · Cited by 163
A review of tigecycline — the first glycylcycline
Peterson, L. R. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(09)70005-6 · Cited by 161
First Report of KPC-2-Producing Klebsiella pneumoniae Strains in Brazil
Monteiro, J., Santos, A. F., Asensi, M. D., Peirano, G., & Gales, A. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00736-08 · Cited by 158
Endimiani, A., DePasquale, J. M., Forero, S. V. C., Pérez, F., Hujer, A. M., Roberts-Pollack, D., Fiorella, P. D., Pickens, N. M., Kitchel, B., Casiano-Colón, A. E., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp327 · Cited by 157
Elemam, A., Rahimian, J., & Mandell, W. (2009) · Clinical Infectious Diseases · doi:10.1086/600042 · Cited by 156
Poirel, L., Castanheira, M., Carrër, A., Rodriguez, C. P., Jones, R. N., Smayevsky, J., & Nordmann, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00022-11 · Cited by 155
The Epidemiology of Nosocomial Infections Caused byKlebsiella pneumoniae
Jarvis, W. R., Munn, V. P., Highsmith, A. K., Culver, D. H., & Hughes, J. M. (1985) · Infection Control · doi:10.1017/s0195941700062639 · Cited by 154
Metallo-β-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues
Cornaglia, G., Akova, M., Amicosante, G., Cantón, R., Cauda, R., Docquier, J., Edelstein, M. V., Frère, J., Füzi, M., Galleni, M., et al. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.10.008 · Cited by 151
Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom
Woodford, N., Zhang, J., Warner, M., Kaufmann, M. E., Matos, J., MacDonald, A., Brudney, D., Sompolinsky, D., Navon‐Venezia, S., & Livermore, D. M. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn396 · Cited by 149
Jaruratanasirikul, S., Sriwiriyajan, S., & Punyo, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1337-1339.2005 · Cited by 149
Doi, Y., Potoski, B. A., Adams‐Haduch, J. M., Sidjabat, H. E., Pasculle, A. W., & Paterson, D. L. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01408-08 · Cited by 147
Status report on carbapenemases: challenges and prospects
Patel, G., & Bonomo, R. A. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.28 · Cited by 146
Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae
Landman, D., Bratu, S., & Quale, J. M. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.012575-0 · Cited by 145
Crystal Structure of KPC-2: Insights into Carbapenemase Activity in Class A β-Lactamases ,
Ke, W., Bethel, C. R., Thomson, J. M., Bonomo, R. A., & van den Akker, F. (2007) · Biochemistry · doi:10.1021/bi700300u · Cited by 144
Calfee, D. P., & Jenkins, S. G. (2008) · Infection Control and Hospital Epidemiology · doi:10.1086/590661 · Cited by 141
Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 β-lactamase resistant to colistin
Κοντοπούλου, Κ., Protonotariou, E., Vasilakos, K., Kriti, M., Koteli, A., Antoniadou, E., & Sofianou, D. (2010) · Journal of Hospital Infection · doi:10.1016/j.jhin.2010.03.021 · Cited by 138
Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece)
Maltezou, H. C., Giakkoupi, P., Maragos, A., Bolikas, E., Raftopoulos, V., Papahatzaki, H., Vrouhos, G., Liakou, V., & Vatopoulos, A. C. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.01.010 · Cited by 135
Endimiani, A., Choudhary, Y., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00641-09 · Cited by 133
Rapid Detection of bla KPC Carbapenemase Genes by Real-Time PCR
Hindiyeh, M. Y., Smollen, G., Grossman, Z., Ram, D., Davidson, Y., Mileguir, F., Vax, M., Ben-David, D., Tal, I., Rahav, G., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00661-08 · Cited by 133
Detection of KPC Carbapenem-Hydrolyzing Enzymes in Enterobacter spp. from Brooklyn, New York
Bratu, S., Landman, D., Alam, M., Tolentino, E., & Quale, J. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.776-778.2005 · Cited by 133
Structural basis for the broad-spectrum inhibition of metallo-β-lactamases by thiols
Liénard, B. M. R., Garau, G., Horsfall, L., Karsisiotis, A. I., Damblon, C., Lassaux, P., Papamicaël, C. A., Roberts, G. C. K., Galleni, M., Dideberg, O., et al. (2008) · Organic & Biomolecular Chemistry · doi:10.1039/b802311e · Cited by 129
Weil‐Weiner, Y., Rudensky, B., Yinnon, A. M., Kopuit, P., Schlesinger, Y., Broide, E., Lachish, T., & Raveh, D. (2009) · Journal of Hospital Infection · doi:10.1016/j.jhin.2009.07.022 · Cited by 128
Munoz-Price, L. S., Hota, B. N., Stemer, A., & Weinstein, R. A. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/644751 · Cited by 126
Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase - United States, 2010.
(2010) · PubMed · Cited by 124
Bratu, S., Brooks, S., Burney, S. N., Kochar, S., Gupta, J., Landman, D., & Quale, J. M. (2007) · Clinical Infectious Diseases · doi:10.1086/512370 · Cited by 122
Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary
Tóth, Á., Damjanova, I., Puskás, E., Jánvári, L., Farkas, M., Dobák, A., Böröcz, K., & Pászti, J. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-0921-3 · Cited by 119
Weisenberg, S. A., Morgan, D. J., Espinal-Witter, R., & Larone, D. H. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.02.004 · Cited by 113
Lee, J., Patel, G., Huprikar, S. S., Calfee, D. P., & Jenkins, S. G. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02466-08 · Cited by 110
Ktari, S., Arlet, G., Mnif, B., Gautier, V., Mahjoubi, F., Jmeaa, M. B., Bouaziz, M., & Hammami, A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00663-06 · Cited by 109
Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint
Burkhardt, O., Rauch, K., Kaever, V., Hadem, J., Kielstein, J. T., & Welte, T. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.01.015 · Cited by 106
Gregory, C. J., Llata, E., Stine, N. W., Gould, C., Santiago, L. M., Vázquez, G. J., Robledo, I. E., Srinivasan, A., Goering, R. V., & Tomashek, K. M. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/651670 · Cited by 104
Berçot, B., Poirel, L., & Nordmann, P. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2011.08.016 · Cited by 103
Wernli, D., Haustein, T., Conly, J. M., Carmeli, Y., Kickbusch, I., & Harbarth, S. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001022 · Cited by 102
The Spread ofKlebsiella pneumoniaeCarbapenemase–ProducingK. pneumoniaeto Upstate New York
Lomaestro, B. M., Tobin, E. H., Shang, W., & Gootz, T. D. (2006) · Clinical Infectious Diseases · doi:10.1086/505598 · Cited by 102
Endimiani, A., Carias, L. L., Hujer, A. M., Bethel, C. R., Hujer, K. M., Pérez, F., Hutton, R. A., Fox, W. R., Hall, G. S., Jacobs, M. R., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00158-08 · Cited by 101
Voets, G. M., Fluit, A. C., Scharringa, J., Stuart, J. W. T. C., & Hall, M. A. L. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.01.005 · Cited by 99
Kwak, Y. G., Choi, S., Choo, E. J., Chung, J.-W., Jeong, J., Kim, N. J., Woo, J., Ryu, J., & Kim, Y. S. (2005) · Microbial Drug Resistance · doi:10.1089/mdr.2005.11.165 · Cited by 98
Carbapenem-Resistant Klebsiella pneumoniae in Post-Acute-Care Facilities in Israel
Ben-David, D., Masarwa, S., Navon‐Venezia, S., Mishali, H., Fridental, I., Rubinovitch, B., Smollan, G., Carmeli, Y., Schwaber, M. J., & Israel PACF CRKP (Post-Acute-Care Facility Carbapenem-Resistant Klebsiella pneumoniae) Working Group (2011) · Infection Control and Hospital Epidemiology · doi:10.1086/661279 · Cited by 98
Yamaguchi, Y., Jin, W., Matsunaga, K., Ikemizu, S., Yamagata, Y., Wachino, J.-I., Shibata, N., Arakawa, Y., & Kurosaki, H. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701031n · Cited by 93
Urban, C. M., Bradford, P. A., Tuckman, M., Segal‐Maurer, S., Wehbeh, W., Grenner, L., Colon‐Urban, R., Mariano, N., & Rahal, J. J. (2008) · Clinical Infectious Diseases · doi:10.1086/588048 · Cited by 92
Zuckerman, T., Benyamini, N., Sprecher, H., Fineman, R., Finkelstein, R., Rowe, J. M., & Oren, I. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.279 · Cited by 86
Tsakris, A., Poulou, A., Themeli-Digalaki, K., Voulgari, E., Pittaras, T. E., Sofianou, D., Pournaras, S., & Petropoulou, D. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01314-09 · Cited by 81
Adaptive resistance to cationic compounds in Pseudomonas aeruginosa
Skiada, A., Markogiannakis, A., Plachouras, D., & Daikos, G. L. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.11.019 · Cited by 80
Self-citationKinetics Study of KPC-3, a Plasmid-Encoded Class A Carbapenem-Hydrolyzing β-Lactamase
Alba, J., Ishii, Y., Thomson, K. S., Moland, E. S., & Yamaguchi, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4760-4762.2005 · Cited by 80
Fatal cross infection by carbapenem‐resistant Klebsiella in two liver transplant recipients
Mathers, A. J., Cox, H. L., Bonatti, H., Kitchel, B., Brassinga, A. K. C., Wispelwey, B., Sawyer, R. G., Pruett, T. L., Hazen, K. C., Patel, J. B., et al. (2009) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2009.00374.x · Cited by 78
Penicillin-derived inhibitors that simultaneously target both metallo- and serine-β-lactamases
Buynak, J. D., Chen, H., Vogeti, L., Gadhachanda, V. R., Buchanan, C. A., Palzkill, T. G., Shaw, R. W., SPENCER, J. M., & Walsh, T. R. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.037 · Cited by 77
Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1
Loli, A. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl302 · Cited by 77
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland
Baraniak, A., Izdebski, R., Herda, M., Fiett, J., Hryniewicz, W., Gniadkowski, M., Kern-Zdanowicz, I., Filczak, K., & Łopaciuk, U. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00436-09 · Cited by 76
Bilavsky, E., Schwaber, M. J., & Carmeli, Y. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32833b3571 · Cited by 74
Daly, M. W., Riddle, D. J., Ledeboer, N. A., Dunne, W. M., & Ritchie, D. J. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.7.1052 · Cited by 72
Suh, J.-Y., Son, J. S., Chung, D. R., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00762-09 · Cited by 70
Carattoli, A., Aschbacher, R., March, A., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq269 · Cited by 69
Nagano, R., Adachi, Y., Imamura, H., Yamada, K., Hashizume, T., & Morishima, H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2497 · Cited by 69
Jeon, M., Choi, S., Kwak, Y. G., Chung, J.-W., Lee, S., Jeong, J., Woo, J. H., & Kim, Y. S. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.08.014 · Cited by 68
Ciobotaro, P., Oved, M., Nadir, E., Bardenstein, R., & Zimhony, O. (2011) · American Journal of Infection Control · doi:10.1016/j.ajic.2011.05.004 · Cited by 67
Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae
Patel, N., Harrington, S. M., Dihmess, A., Woo, B., Masoud, R., Martis, P., Fiorenza, M., Graffunder, E. M., Evans, A. M., McNutt, L., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr156 · Cited by 67
Munoz-Price, L. S., Cuesta, C. D. L., Adams, S., Wyckoff, M. M., Cleary, T., McCurdy, S. P., Huband, M. D., Lemmon, M. M., Lescoe, M., Dib-Hajj, F. B., et al. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/656243 · Cited by 62
Humphries, R. M., Kelesidis, T., Bard, J. D., Ward, K. W., Bhattacharya, D., & Lewinski, M. A. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.023010-0 · Cited by 61
Souli, M., Rekatsina, P. D., Chryssouli, Z., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01271-08 · Cited by 57
Fukigai, S., Alba, J., Kimura, S., Iida, T., Nishikura, N., Ishii, Y., & Yamaguchi, K. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.10.011 · Cited by 57
Bulik, C. C., Christensen, H., Li, P., Sutherland, C. A., Nicolau, D. P., & Kuti, J. L. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01190-09 · Cited by 56
Mendes, R. E., Bell, J. M., Turnidge, J. D., Yang, Q., Yu, Y., Sun, Z., & Jones, R. N. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01185-07 · Cited by 56
Nadkarni, A. S., Schliep, T., Khan, L., & Zeana, C. B. (2009) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.013 · Cited by 54
Rodríguez-Avial, C., Rodríguez-Avial, I., Merino, P., & Picazo, J. J. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03482.x · Cited by 45
Patel, G., Pérez, F., & Bonomo, R. A. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283404373 · Cited by 40
First Report of Klebsiella oxytoca Strain Coproducing KPC-2 and IMP-8 Carbapenemases
Li, B., Sun, J., Liu, Q., Han, L., Huang, X.-H., & Ni, Y. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01670-10 · Cited by 40
Characterization of the IncA/C plasmid pCC416 encoding VIM-4 and CMY-4 β-lactamases
Colinon, C., Miriagou, V., Carattoli, A., Luzzaro, F., & Rossolini, G. M. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm171 · Cited by 39
Marschall, J., Tibbetts, R. J., Dunne, W. M., Frye, J. G., Fraser, V. J., & Warren, D. K. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02123-08 · Cited by 39
Nagano, R., Adachi, Y., Hashizume, T., & Morishima, H. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.3.271 · Cited by 36
Moloughney, J. G., Thomas, J. D., & Toney, J. H. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.11.042 · Cited by 35
Wiskirchen, D. E., Koomanachai, P., Nicasio, A. M., Nicolau, D. P., & Kuti, J. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01253-10 · Cited by 35
First IMP-1-producing Klebsiella pneumoniae isolate in Turkey
Aktaş, Z., Bal, Ç., Midilli, K., Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01480.x · Cited by 31
Pasterán, F. G., Lucero, C., Soloaga, R. N., Rapoport, M., & Corso, A. C. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01178-10 · Cited by 31
New molecules from old classes: revisiting the development of beta-lactams.
Page, M. G. P., & Heim, J. (2009) · PubMed · Cited by 25
Ho, V. P., Jenkins, S. G., Afaneh, C. I., Turbendian, H. K., Nicolau, D. P., & Barie, P. S. (2011) · Surgical Infections · doi:10.1089/sur.2010.072 · Cited by 23
Isolation of the first metallo-beta-lactamase producing Klebsiella pneumoniae in Lebanon.
Daoud, Z., Hobeika, E., Choucair, A., & Rohban, R. (2008) · PubMed · Cited by 23
Chronic hepatitis C infection and insulin resistance: two best friends
Abenavoli, L., & Almasio, P. L. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.72 · Cited by 22
Petersen, P. J., Jones, C. H., Venkatesan, A. M., Mansour, T. S., Projan, S. J., & Bradford, P. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01047-08 · Cited by 21
Buehlmann, M., Fankhauser, H., Laffer, R., Bregenzer, T., & Widmer, A. F. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/651309 · Cited by 19
Zuckerman, T., Benyamini, N., Sprecher, H., Fineman, R., Finkelstein, R., Rowe, J. M., & Oren, I. (2010) · Cited by 19
Cited by
Molecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092
Tackling antibiotic resistance: the environmental framework
Berendonk, T. U., Manaia, C. M., Merlin, C., Fatta-Kassinos, D., Cytryn, E., Walsh, F., Bürgmann, H., Sørum, H., Norström, M., Pons, M.-N., et al. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3439 · Cited by 2,338
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
Munoz-Price, L. S., Poirel, L., Bonomo, R. A., Schwaber, M. J., Daikos, G. L., Cormican, M., Cornaglia, G., Garau, J., Gniadkowski, M., Hayden, M. K., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70190-7 · Cited by 1,627
Self-citationMathers, A. J., Peirano, G., & Pitout, J. D. D. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00116-14 · Cited by 872
Metadata
- Authors
- Tzouvelekis, L. S., Markogiannakis, A., Psichogiou, M., Tassios, P. T., & Daikos, G. L.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2012-10
- Volume
- 25
- Issue
- 4
- Pages
- 682-707
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2117508830
- Cited by
- 1,191
- References
- 190
- FWCI
- 36.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.